Clavulanic Acid

克拉维酸

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameClavulanic Acid
Drug Alias Nameacide clavulanique克拉布兰酸克拉椎酸Clavulanateacidum clavulanicum +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta Lactamase inhibitors
TargetsBeta Lactamase
Therapy Area/IndicationsDepressive Disorder, MajorTobacco Use DisorderCocaine-Related Disorders +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of MissouriTemple University
Inactive CompaniesRexahn Pharmaceuticals Inc
Active IndicationsTobacco Use DisorderCocaine-Related DisordersBacterial Infections
Inactive IndicationsDepressive Disorder, MajorDiabetes ComplicationsErectile Dysfunction

Other Information

ATC CodeJ01
Related LinksWikipediaDrugBankKEGG